RecruitingNot ApplicableNCT06033378

Blood Pressure Treatment in ICU Patients with Subarachniodal Haemorrhage.

Blood Pressure Treatment in ICU Patients with Subarachniodal Haemorrhage. -Can Blood Pressure Be Used As a Surrogate Marker for Blood Flow

Sponsor

Umeå University

Enrollment

30 participants

Start Date

Sep 1, 2023

Study Type

INTERVENTIONAL

Conditions

Blood Pressure Subarachnoid Hemorrhage Aneurysm Cerebral

Summary

An MRI study to examine the relationship between blood pressure and cerebral blood flow in patients with subarachnoidal hemorrhage and suspect or verified vasospasm.

Eligibility

Min Age: 18 Years

Inclusion Criteria2

Coiled or clipped aneurysm
Suspected or confirmed vasospasm

Exclusion Criteria6

BMI \>30
Pregnancy
Pacemaker or other MRI contraindications
Severe congestive heart failure (NYHA III-IV) or cardiac arrhythmia.
Severe respiratory failure or FiO2 \>0.6
Severe kidney failure

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood pressure elevation

Increasing systemic blood pressure for measurement of cerebral blood flow changes

Locations(1)

Umeå University Hospital

Umeå, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06033378

Related Trials

Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure

NCT070705831 location

This Three-year Observational Study Involves Patients of All Ages Undergoing Endovascular Treatment for Various Cerebral or Spinal Vascular Conditions. It Aims to Assess Pre- and Post-operative Clinical Conditions, Report Complications, and Identify Preoperative Indicators of Treatment Outcomes. Pat

NCT068057211 location